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Abstract
Little information is available on temporal trends in sodium intake in the U.S. population using 
urine sodium excretion as a biomarker. Our aim was to assess 1988–2010 trends in estimated 24-h 
urine sodium (24hUNa) excretion among U.S. adults (20–59 y) participating in the cross-sectional 
National Health and Nutrition Examination Survey (NHANES). We used subsamples from a 
1988–1994 convenience sample, a 2003–2006 1/3 random sample, and a 2010 1/3 random sample 
to comply with resource constraints. We estimated 24hUNa excretion from measured sodium 
concentrations in spot urine samples by use of calibration equations (for men and women) derived 
from the INTERSALT study. Estimated 24hUNa excretion increased over the 20-y period (1988–
1994, 2003–2006, and 2010) [mean ± SEM (n)]: 3160 ± 38.4 mg/d (1249), 3290 ± 29.4 mg/d 
(1235), and 3290 ± 44.4 mg/d (525), respectively (Ptrend = 0.022). We observed significantly 
higher mean estimated 24hUNa excretion in each survey period (P <0.001) for men compared to 
women (31–33%) and for persons with higher body mass index (BMI) (32–35% for obese vs. 
normal weight) or blood pressure (–26% for hypertensive vs. normal blood pressure). After 
adjusting for age, sex, and race-ethnicity, temporal trends in mean estimated 24hUNa excretion 
remained statistically significant (Ptrend = 0.004). We observed no temporal trends in mean 
estimated 24hUNa excretion among BMI subgroups, nor after adjusting for BMI. While several 
limitations apply to this analysis (the use of a convenience sample in 1988–1994 and using 
estimated 24hUNa excretion as a biomarker of sodium intake), these first NHANES data suggest 
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that mean estimated 24hUNa excretion increased slightly in U.S. adults over the last 2 decades and 
this increase may be explained by a shift in the distribution of BMI.
INTRODUCTION
The U.S. population consumes too much sodium, even though governmental agencies and 
professional health organizations continue to recommend reducing sodium intake to lower 
the risk of hypertension and cardiovascular disease (1–3). Estimates from What We Eat in 
America show that the U.S. population aged ≥2 y consumed on average 3463 mg/d of 
sodium from food and beverages in 2009–2010 (4), which is substantially higher than the 
Healthy People 2020 objective of 2300 mg/d of sodium from all sources (5), the Institute of 
Medicine recommended tolerable upper intake level for adults of 2300 mg/d (2), the 
recommended limits in Dietary Guidelines for Americans of <2300 mg/d (1500 mg/d for 
specific subpopulations) (3), and the American Heart Association recommendation of ≤1500 
mg/d (1).
Based on historic dietary data, mean sodium intake in the U.S. population increased among 
all age groups between NHANES I (1971–1974) and III (1988–1994), but seemed to level 
off between NHANES III, 1999–2000 (2,6), and 2003–2008 (7). In contrast, an analysis of 
sodium intake estimated from 24-h urine collections in 38 studies conducted in the United 
States, suggested no significant temporal trends in sodium intake between 1957 and 2003 
(8). Although a recent study suggests the current dietary intake methods used in NHANES 
are valid for estimating population sodium intake among healthy, weight stable adults aged 
30–69 y (9), dietary assessment and food coding methods changed somewhat over time, 
which may partially explain the discrepancy in results. Another potential explanation is that 
the studies assessing sodium using 24-h urine collections were not nationally representative.
The Institute of Medicine in their report on strategies to reduce sodium intake in the United 
States recommended exploring the use of stored urine samples for monitoring trends in U.S. 
sodium intake (10). The analysis of urine collected during a 24-h period reflects about 90% 
of the ingested sodium when complete and is considered to be an accurate and reliable 
measure of sodium intake (2). Because 24-h urine collections are challenging (11), 
burdensome for the participant, and could negatively affect the quality of the samples and 
the response rate to other NHANES components, the survey historically only collected a 
“casual” (random) urine sample, also called “spot” urine. These samples were used to assess 
environmental analytes and measure trace elements including iodine, but sodium was not 
assessed. While spot samples are not likely to provide a desirable level of accuracy for the 
purposes of estimating individual intake (12), a recent study suggests spot urine samples 
may be used to estimate average sodium intake among Western (North American and 
European) adults aged 20–59 y (13).
To generate the first nationally representative data on temporal trends in sodium intake in 
U.S. adults using estimated 24-h urine sodium (24hUNa)7 excretion as a biomarker, we 
7Abbreviations used: 24hUNa, 24-h urine sodium; BP, blood pressure; MEC, Mobile Examination Center; NCHS, National Center for 
Health Statistics.
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measured sodium in selected surplus urine spot samples from 3 NHANES survey periods 
(1988–1994, 2003–2006, and 2010). We applied the newly available calibration equations 
derived from the Western INTERSALT study (13) to these data to generate estimated 
24hUNa excretion. Here we describe the temporal trends over 2 decades in sodium excretion 
by demographic and health characteristics and compare estimated 24-h sodium excretion 
from spot urine with dietary sodium intake.
SUBJECTS AND METHODS
The NHANES has been collecting cross-sectional data on the health and nutritional status of 
the U.S. population first as periodic surveys (early 1970s to middle 1990s), and since 1999 
as a continuous survey conducted in 2-y survey periods (14). The survey, designed and 
carried out by the National Center for Health Statistics (NCHS) at the Centers for Disease 
Control and Prevention (CDC), has a stratified, multistage, probability sample design and is 
representative of the civilian, non-institutionalized U.S. population. The NHANES combines 
home interviews with health tests performed in a Mobile Examination Center (MEC), where 
biologic samples are collected for biochemical analyses. All respondents gave their 
informed consent, and the NHANES protocol was approved by the NCHS Research Ethics 
Review Board.
Study design
The current cross-sectional study is based on a surplus sample proposal approved by NCHS 
to measure urine sodium in randomly selected spot urine samples from 3 NHANES survey 
periods: 1988–1994, 2003–2006, and 2010 (limited to 1 y due to resource constraints). 
Information on the urine samples used in this study is provided in Supplemental Methods 1.
Sample selection and exclusion criteria
The unweighted examination response rates for the overall sample (and for ages 20–59 y) 
were 78% (73%) for 1988–1994, 77% (73%) for 2003–2006, and 77% (77%) for 2010 (15). 
To optimize resources, we randomly sampled NHANES participants for laboratory analyses, 
selecting among participants who provided informed consent for further testing of stored 
samples and had non-missing data on urine creatinine concentration and dietary sodium 
intake. In addition, we applied exclusion criteria that may affect urine sodium excretion: 
pregnant women, participants who reported taking BP medications, angiotensin converting 
enzyme inhibitors or angiotensin II inhibitors, or a diuretic. We did not a priori exclude 
participants with severe renal disease (stages 3–5) because this would have negatively 
affected the sample size of participants with hypertension. We limited the first 2 survey 
periods (NHANES 1988–1994 and 2003–2006) to the adult population aged 20–59 y 
because this was the only age range for which we had urine samples in NHANES III and 
because older persons are more likely to have chronic conditions that could affect urine 
sodium excretion. Sample selection was based on BP and dietary sodium intake to ensure a 
wide range of values for these 2 related measures. All untreated hypertensive participants 
that fit the above criteria were included. The group of non-hypertensive participants was 
stratified into 8 groups based on their BP category (normal or pre-hypertension) and sodium 
intake quartile from 1 dietary recall. Participants were then randomly selected with 
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approximately equal numbers per strata. We selected 1249 participants from 1992 samples 
that met our criteria in NHANES 1988–1994 (Supplemental Fig. 1) (16). We selected 1241 
participants in NHANES 2003–2006: 853 non-hypertensive participants from a 1/3 urine 
random subsample and 388 participants with hypertension from the full examination sample 
(Supplemental Fig. 2) (17). For NHANES 2010 we selected 525 persons 20–59 y old that 
met our criteria from a 1/3 urine random subsample (Supplemental Fig. 3) (18).
Laboratory methods
Urine sodium was measured at the CDC laboratory via ion-selective electrode (ISE) using 
the Cobas ISE/Na+, K+, Cl− assay performed on the Roche Modular P instrument (Roche 
Diagnostics Corporation, Indianapolis, IN) (19). The CV measured in 4 urine quality control 
pools (56.6–169 mmol/L) were <2.5% (n = 144 runs). The assay performance is described in 
more detail elsewhere ([16–18]; Supplemental Methods 1).
Estimation of 24-h urine sodium excretion from spot samples
We used previously published calibration equations derived from the Western INTERSALT 
study (13) to predict 24hUNa excretion from spot urine sodium concentrations 
(Supplemental Methods 1). The equations were derived from 2841 male and 2852 female 
North American and European adults aged 20–59 y covering a low to high 24hUNa 
excretion group mean of 3386–5520 and 2709–3852 mg, respectively. They differed by sex 
and contained spot sodium, potassium, and creatinine concentrations as well as age and 
BMI.
Dietary sodium intake
Data on sodium intake from the diet were assessed using 24-h dietary recalls (Supplemental 
Methods 1). In NHANES 1988–1994, each participant had 1 24-h dietary recall 
administered in person at the MEC (about 5% of participants had a second recall 
administered by telephone 3–10 d later). In NHANES 2003–2006 and NHANES 2010, each 
participant had 2 24-h dietary recalls. We used the sodium intake information from the first 
recall as it was close in time to the MEC-provided spot urine sample.
Covariates
We categorized the covariates as follows: age (20–39 y and 40–59 y); race-ethnicity (non-
Hispanic white [NHW], non-Hispanic black [NHB], and Mexican American [MA]; other 
racial-ethnic groups were included in overall estimates but not separately); BMI (normal 
[18.5–<25], overweight [25–<30], and obese [≥30] kg/m2; underweight persons were 
included in overall estimates but not separately; [20]); BP (normal [SBP <120, DBP <80], 
prehypertension [SBP 120–139 or DBP 80–89], and hypertension [SBP ≥140 or DBP ≥90] 
mm Hg; [21]).
Statistical analyses
Statistical analyses were performed using SAS (version 9.3, SAS Institute Inc., Cary, NC) 
and SUDAAN (version 11, RTI, Research Triangle Park, NC) software. The specialized 
SUDAAN software considered the complex survey design by incorporating the survey 
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weights to account for the unequal probabilities of selection and adjustment for non-
response. The NHANES 1988–1994 urine samples were a convenience sample of NHANES 
examinees (16), which cannot be assumed to be representative of the U.S. population. We 
made several attempts to address this limitation. We verified that the unweighted frequency 
distributions for age, sex and race-ethnicity compared for adults 20–59 y of age in the full 
NHANES sample, the full convenience sample, and our study sample (data not shown). The 
participant’s choice to volunteer for the convenience sample was made without any 
knowledge of their urine sodium value and participant selection was at about equal rate from 
each location throughout the NHANES 1988–1994. Given these conditions, we created new 
sample weights taking into account the subsampling strategy and post-stratifying them to the 
NHANES III examination weights (Supplemental Methods 1). We then confirmed that the 
weighted frequency distributions for demographic characteristics (age, sex, race-ethnicity) 
and the weighted means for other participant key characteristics (BMI, BP, dietary sodium 
intake, caloric intake and urine creatinine) did not differ between our study sample and the 
full NHANES sample (adults 20–59 y of age, pregnant women excluded) (Supplemental 
Table 1). The data from NHANES 2003–2006 (17) and NHANES 2010 (18) were 
subsamples of the full samples, therefore new sample weights were created that took into 
account the subsampling strategy and non-response to the urine collection. These sample 
weights were post-stratified to the respective original examination sample weights. The 
single year data from 2010 are nationally representative and are derived from a probability 
sample. We calculated variance estimates using the delete-1 jackknife method to allow 
combining data from the 3 survey periods (Supplemental Methods 1).
We excluded a few participants who had been randomly selected due to missing data 
(Supplemental Methods 1). The estimated 24hUNa excretion distribution was close to 
Gaussian, requiring no transformation. The dietary sodium intake distribution was 
transformed to normality using a logarithmic transformation. We plotted weighted frequency 
distribution curves of estimated 24hUNa excretion by survey period and by BMI. We 
assessed bivariate associations between mean estimated 24hUNa excretion and geometric 
mean dietary sodium intake and categories of age, sex, race-ethnicity, BMI, and BP for each 
NHANES survey period. We used the Wald F test to compare means across categories and a 
linear trend test to assess temporal trends within each variable category. Using survey period 
as a categorical variable, we found no significant interactions between survey period and the 
other independent variables in a multiple linear regression model. Thus, we did not stratify 
by survey period in subsequent analyses that evaluated whether adjusting for certain 
covariates had an effect on the bivariate associations (Wald F test to compare adjusted 
means across categories). The BMI distribution in U.S. adults has shifted towards the right 
between 1980 and 1999, with more recent data suggesting a leveling off of this trend (22), 
and BMI is correlated to energy and sodium intake (12). Thus, our main multivariate model 
1 only controlled for the standard demographic covariates (age, sex, and race-ethnicity). 
However, we assessed results from model 2 in which we additionally controlled for BMI to 
provide further insight into the potential reasons for change in sodium excretion. Statistical 
significance was defined as P <0.05. No adjustment was made for multiple comparisons.
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To assess the association between sodium excretion (as a measure of recent intake) and 
sodium intake (from the 24-h period preceding the urine sample), we calculated Spearman 
correlation coefficients for spot urine concentration (mmol/L), creatinine corrected spot 
urine sodium concentration (mmol/g), and estimated 24hUNa excretion (mg/d) vs. usual 
dietary sodium intake (mg/d). We categorized individuals into quartiles of usual dietary 
sodium intake and calculated the mean estimated 24hUNa excretion for each intake quartile 
and NHANES survey period. The estimation of usual dietary sodium intake is described in 
Supplemental Methods 1.
To provide reference information for urine sodium excretion, we calculated the mean and 
selected percentiles (5th, 50th, and 95th) for spot urine concentrations (mmol/L), creatinine 
corrected spot urine sodium concentrations (mmol/g), and estimated 24hUNa excretion 
(mg/d) by demographic and health characteristics. Values in the text are means (geometric 
means) ± SEM. All reported estimates had a relative SEM of ≤30% and were considered 
statistically reliable.
RESULTS
A description of the demographic and health characteristics of the study population assessed 
in this analysis showed that changes occurred in the distributions of age, race-ethnicity, 
BMI, and BP status, but not sex (Table 1). The distribution of estimated 24hUNa excretion 
varied slightly by survey period with a range of approximately 1000 to 7000 mg/d (Figure 
1a) and shifted notably to higher values with higher BMI when all survey years were 
combined (Figure 1b).
For the 3 survey periods (1988–1994, 2003–2006, and 2010) the estimated 24hUNa 
excretions among adults aged 20–59 y were 3160 ± 38.4 mg/d, 3290 ± 29.4 mg/d, and 3290 
± 44.4 mg/d, respectively, (Ptrend = 0.022, Table 2). Slight increases in estimated 24hUNa 
excretion from 1988–1994 to 2010 were statistically significant among persons 20–39 y old, 
men, women, and persons with normal BP. Among other age, race-ethnic, BMI, or BP 
subgroups we found no temporal trends in estimated 24hUNa excretion. Although estimated 
24hUNa excretion among non-Hispanic black adults increased the most of all the subgroups 
examined, from 3260 mg/d in 1988–1994 to 3470 mg/d in 2010, the temporal trend was not 
statistically significant (Ptrend = 0.06). Within each survey period, men had significantly 
higher estimated 24hUNa excretion compared with women (31–33%) and estimated 
24hUNa excretion varied significantly by BMI (32–35% higher for obese vs. normal weight) 
and BP (17–26% higher for hypertensive vs. normal blood pressure) status. Within the first 
2 survey periods, but not the last survey period, estimated 24hUNa excretion varied 
significantly by race-ethnic groups. During all 3 time periods, the highest estimated 24hUNa 
excretion was among obese participants and the lowest among women.
Dietary sodium intakes for the 3 survey periods appeared higher than the estimated 24hUNa 
excretion, the error in the mean was larger, and we found no temporal trend: 3280 ± 83.3 
mg/d, 3270 ± 68.2 mg/d, and 3400 ± 87.6 mg/d, respectively (Ptrend = 0.34, Table 3). 
However, we noted a statistically significant temporal increase in dietary sodium intake for 
women, obese and prehypertensive persons. As seen with the estimated 24hUNa excretion, 
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men had significantly higher dietary sodium intakes compared with women (33–56%) for 
each survey period. Dietary sodium intake did not vary significantly by the other 
demographic and health characteristics, except for race-ethnicity in 2003–2006 and BP in 
2010.
After adjusting for age, sex, race-ethnicity and survey period (model 1), the estimated 
24hUNa excretion was significantly different by age (P = 0.004), sex (P <0.001), and race-
ethnicity (P <0.001) and we observed a small (142 mg/d) but significant (Ptrend = 0.004) 
increase in estimated 24hUNa excretion over the 3 time periods: 3190, 3260, and 3330 mg/d 
(Table 4). Temporal trends in estimated 24hUNa excretion were also statistically significant 
after adjusting individually for age (Ptrend = 0.028), sex (Ptrend <0.001), or BP status (Ptrend 
= 0.007) (data not shown). The temporal trend was not statistically significant after adjusting 
for race-ethnicity (Ptrend = 0.053) and we found no trend after adjusting for BMI (Ptrend = 
0.65) (data not shown). When we adjusted for BMI in addition to the demographic variables 
(model 2), we found no temporal trend in estimated 24hUNa excretion (Ptrend = 0.22). The 
model 2 adjusted estimated 24hUNa excretion was statistically significant by sex, race-
ethnicity, and BMI. The significant positive association between estimated 24hUNa 
excretion and BMI found in the bivariate analysis (Table 2) was therefore maintained after 
adjusting for demographic variables.
Regardless of the model, temporal trends in dietary sodium intake were not statistically 
significant (Ptrend = 0.07 for model 1; Ptrend = 0.10 for model 2; Table 4). The adjusted 
dietary sodium intake was significantly different by age, sex, and race-ethnicity, but not by 
BMI (model 2).
For each survey period, we found moderate statistically significant correlations between the 
estimated 24hUNa excretion and the dietary sodium intake (r = 0.31 [1988–1994], 0.35 
[2003–2006], and 0.34 [2010]), but only weak significant correlations (r ≤0.2) for the urine 
spot sodium concentration or the creatinine corrected urine spot sodium concentration 
(Supplemental Table 2). The estimated 24hUNa excretion increased linearly by quartile of 
usual sodium intake for each survey period (Q1–Q4: 2650–3700 [1988–1994], 2790–3770 
[2003–2006], and 2710–3820 [2010]; Figure 2).
Means and selected percentiles of the measured urine sodium concentrations and the 
creatinine corrected values in spot samples for the 3 survey periods by demographic and 
health characteristics are presented in Supplemental Tables 3 and 4. Selected percentiles 
(5th, 50th, and 95th) for estimated 24hUNa excretion provide information on the normal 
range of a single urine sample (Supplemental Table 5). While these data do not allow an 
interpretation of the population percentiles of sodium intake, they may be of interest to 
investigators who have similar spot urine data and would like to compare it to data for U.S. 
adults.
DISCUSSION
In 2010, estimates of sodium intake from estimated 24hUNa excretion (3290 mg/d, Table 2) 
or dietary sodium intake (3400 mg/d, Table 3), were well above recommended limits. From 
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1988–2010, estimated 24hUNa excretion increased slightly among U.S. adults aged 20–59 y 
participating in the cross-sectional NHANES before and after adjusting for age, sex, and 
race-ethnicity. Across all 3 time periods, estimated 24hUNa excretion was strongly and 
positively associated with being male vs. female and with higher BMI and BP. We found no 
temporal trends in estimated 24hUNa excretion among BMI subgroups or after adjusting for 
BMI. Mean dietary sodium intake was also strongly and positively associated with being 
male vs. female, but it was not associated with BMI and did not change over time.
It has been shown that underreporting of energy intake (and thereby sodium intake) is more 
common in persons with higher BMI (23). This may explain the lack of association we 
found between dietary sodium intake and BMI, while we observed a strong and positive 
association between the objectively measured urine biomarker and BMI. Information on 
sodium intake based on urine measures is limited (Supplemental Table 6). In 1985–1987, the 
INTERSALT study related sodium intake, as assessed by a single 24-h urine collection, to 
BP in more than 10000 men and women aged 20–59 y at 52 centers in 32 countries. Among 
the 4 centers in the United States, urine sodium levels (mg/d) ranged from 2232–4012 in 
men and from 2538–3035 in women (24). Approximately 10 y later (1997–1999), the 
INTERMAP study aimed to clarify the role of multiple dietary factors to BP among 4700 
men and women ages 40–59 y in East Asian and Western countries. Sodium intake (mg/d), 
as determined by 2 timed 24-h urine collections, was 4202 in U.S. men and 3272 in U.S. 
women (25). The U.S. Coronary Artery Risk Development in Young Adults (CARDIA) 
study conducted 3 consecutive 24-h urine collections in 920 participants (half Caucasian and 
half African American) aged 25–37 y in 1990–1991. Urine sodium levels (mg/d) were 4430 
and 4550 for African American and white men, respectively, and 3584 and 3612 for African 
American and white women, respectively (24). A recent study that assessed sodium and 
related micronutrient status from timed-spot and 24-h urine samples in young (18–39 y) U.S. 
adults, the 2011 CDC/NIH sodium calibration study, found mean 24hUNa excretion of 3540 
mg/d for men and 3090 mg/d for women (26). These data on 24hUNa excretion are 
generally comparable or slightly higher compared with our findings using spot urine 
samples to estimate 24hUNa excretion (3670 and 2790 mg/d for men for women, 
respectively, model 1). This is expected, given a recent analysis of the aforementioned 
CDC/NIH study suggesting estimated 24hUNa excretion using the INTERSALT equations 
are slightly lower than measured 24hUNa excretion (27).
Recently, Bernstein and Willett published results on trends in 24-h urine sodium excretion 
from a systematic review of 38 U.S. studies, including some of those cited above, conducted 
between 1957–2003 (8). The authors found no change in mean sodium intake over this time 
period and estimated an overall mean (SE) 24hUNa excretion of 3526 (75) mg/d (3911 mg/d 
for males and 3084 mg/d for females). The British Food Safety Agency surveys conducted 
from 1984–2008 also arrived at a similar mean (SD) 24hUNa excretion of 3450 (161) mg/d 
(3894 mg/d for males and 2965 mg/d for females) (28). These 24-h urine sodium excretion 
levels are also quite comparable to our estimated levels and the small differences could be a 
result of different populations, sample types, or time period.
As was previously shown (8,24,25), we also found a strong association between estimated 
24hUNa excretion and sex, with higher sodium excretion in men compared to women, 
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consistent through all 3 survey periods and after adjusting for covariates. We noted sodium 
excretion was strongly (Spearman rho ~0.5; data not shown) and positively associated with 
BMI before and after adjusting for demographic covariates. This may be related to the 
inclusion of BMI in the INTERSALT prediction equations, although others have shown 
24hUNa excretion to be mildly correlated (r = 0.20) with BMI (12). Not surprisingly, given 
the shifts in BMI over the same time period (23), we observed no temporal trends in sodium 
excretion once we adjusted for BMI. Whether or not to adjust for BMI depends on the 
question at hand and has been debated before (29,30). Thus, we presented the trends with 
and without adjusting for BMI.
The correlations between the estimated 24hUNa excretion and the dietary sodium intake in 
our study (Spearman rho = 0.31–0.35 for the 3 survey periods) were comparable to other 
studies, particularly if one considers that they were derived from a single spot urine and a 
single 24-h dietary recall. Reported correlations between 24-h sodium excretion and sodium 
intake are between 0.3 and 0.75 (if multiple 24-h excretions are considered) (31). The 
correlation for the INTERMAP study was 0.42 (4 24-h dietary recalls and 2 timed 24-h 
urines) (32). As expected, we found an association between sodium excretion and intake 
with estimated 24hUNa excretion increasing linearly by quartile of sodium intake for each 
survey period.
One major limitation of our study is that the stored urine from the oldest time period (1988–
1994) was a convenience rather than a probability NHANES sample. This presents the 
question whether the sample is representative of the U.S. population and how much 
confidence can be placed in the statistical testing for temporal trends. Participants in our 
study sample were selected throughout the entire 6-y period and did not differ from 
participants in the full NHANES 1988–1994 sample with regard to demographic 
characteristics or in the central tendency of key variables used in our study. We thus made 
the assumption that our study sample was reasonably representative of the civilian non-
institutionalized U.S. population and we calculated new sample weights to better account for 
potential bias in the way this NHANES 1988–1994 study sample was selected. It is possible 
though that the estimates for 1988–1994 are not generalizable to the target population which 
could affect the observed trends.
While the use of spot urines is currently not recommended for monitoring individual or 
population sodium intake because of the large diurnal variation in sodium excretion (10) and 
may have decreased our ability to detect small differences, a recent study indicated spot 
urines may be of some use for monitoring population mean sodium intake (13). The 
calibration equations we used to estimate 24hUNa excretion were derived from and 
validated in the Western INTERSALT study (13) and also recently validated in U.S. men 
and women (50% African-American) aged 18–39 y (27). However, the INTERSALT 
equation has not been externally validated among the NHANES population, nor among 
adults aged 40 y and older. A minor limitation of our study is that we were not able to 
account for within-person variability, which has been shown to be important even with the 
use of 24-h urine collections, particularly to accurately estimate population percentiles 
(33,34), because the participants in our study were sampled only once.
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Our study has several strengths. It included a large sample of racial and ethnically diverse 
groups of adults from across the U.S. and used weighted data to generate estimates that are 
representative of the U.S. population. However, we applied certain exclusion criteria that 
may affect the generalizability of our findings. The analysis was stratified by various 
demographic and health characteristics, showing first time temporal trends in sodium intake 
in the U.S. population based on a urine sodium measure. While the results are limited to 
adults 20–59 y of age and several limitations apply to the data because they were derived 
from spot urine, these are the only available historic data, as no 24-h urine samples were 
collected in previous NHANES surveys. In summary, we conclude that increases in sodium 
intake among U.S. adults over the last 2 decades are small and may be associated with the 
shift in distribution of BMI. Sodium intake among U.S. adults remains higher than 
recommended levels.
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Smoothed frequency distribution curves of estimated 24-h urine sodium excretion for U.S. 
adults 20–59 y of age by survey period (A) and BMI category (B), NHANES 1988–2010.
To optimize resources, we randomly sampled NHANES participants 20–59 y of age for 
urine sodium analysis based on blood pressure and sodium intake. The 1988–1994 urine 
samples were a convenience sample of 2550 NHANES examinees of which we selected 
1249; for NHANES 2003–2006, we selected 1241 participants from a 1/3 urine random 
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subsample (1 excluded due to extreme BMI, 5 excluded due to missing BMI); for NHANES 
2010, we included data from 525 persons from a 1/3 urine random subsample.
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Mean estimated 24-h urine sodium excretion by sodium intake quartiles for U.S. adults 20–
59 y of age by survey period, NHANES 1988–2010.
Sodium intake quartiles (Q1: <2989; Q2: 2989–<3663; Q3: 3663–<4517; Q4: ≥4517) have 
been determined by using the best linear unbiased predictor values. Error bars represent 95% 
CI. To optimize resources, we randomly sampled NHANES participants 20–59 y of age for 
urine sodium analysis based on blood pressure and sodium intake. The 1988–1994 urine 
samples were a convenience sample of 2550 NHANES examinees of which we selected 
1249; for NHANES 2003–2006, we selected 1241 participants from a 1/3 urine random 
subsample (1 excluded due to extreme BMI, 5 excluded due to missing BMI); for NHANES 
2010, we included data from 525 persons from a 1/3 urine random subsample. Sample sizes 
for sodium intake: 1988–1994, n = 1249 (Q1: 346, Q2: 338, Q3: 333, Q4: 232); 2003–2006, 
n = 1235 (Q1: 309, Q2: 295, Q3: 339, Q4: 292); 2010, n = 507 (Q1: 121, Q2: 172, Q3: 124, 
Q4: 90).
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Table 2
Estimated 24-h urine sodium excretion in U.S. adults aged 20–59 y by demographic and health characteristics, 
NHANES 1988–20101,2
1988–1994 2003–2006 2010 Ptrend value3
mg/d mg/d mg/d
All groups 3160 ± 38.4 3290 ± 29.4 3290 ± 44.4 0.022
Age group
  20–39 y 3130 ± 52.6 3240 ± 38.4 3320 ± 57.9 0.017
  40–59 y 3200 ± 54.9 3350 ± 44.4 3250 ± 67.9 0.54
  P value4 0.40 0.06 0.48
Sex
  Men 3580 ± 50.7 3720 ± 34.7 3740 ± 57.6 0.032
  Women 2690 ± 35.5 2800 ± 32.1 2860 ± 47.0 0.003
  P value4 <0.001 <0.001 <0.001
Race-ethnicity
  Mexican American 3440 ± 49.3 3530 ± 58.0 3410 ± 82.8 0.65
  Non-Hispanic black 3260 ± 49.6 3400 ± 61.9 3470 ± 105 0.06
  Non-Hispanic white 3120 ± 48.8 3230 ± 37.8 3240 ± 63.6 0.10
  P value4 0.012 0.001 0.051
BMI5
  Normal weight 2830 ± 45.3 2830 ± 42.4 2900 ± 60.7 0.44
  Overweight 3330 ± 65.6 3380 ± 40.1 3180 ± 64.1 0.13
  Obese 3730 ± 83.3 3820 ± 49.1 3890 ± 70.1 0.15
  P value4 <0.001 <0.001 <0.001
Blood pressure6
  Normal 2900 ± 51.0 3090 ± 41.6 3070 ± 50.9 0.014
  Prehypertension 3470 ± 57.6 3480 ± 46.9 3580 ± 78.2 0.26
  Hypertension 3640 ± 97.4 3610 ± 51.7 3780 ± 186 0.60
  P value4 <0.001 <0.001 <0.001
1
Values are crude mean estimates ± SEMs (n are the same as in table 1). DBP, diastolic blood pressure; SBP, systolic blood pressure.
2
To optimize resources, we randomly sampled NHANES participants 20–59 y of age for urine sodium analysis based on blood pressure and 
sodium intake. The 1988–1994 urine samples were a convenience sample of 2550 NHANES examinees of which we selected 1249; for NHANES 
2003–2006, we selected 1241 participants from a 1/3 urine random subsample (1 excluded due to extreme BMI, 5 excluded due to missing BMI); 
for NHANES 2010, we included data from 525 persons from a 1/3 urine random subsample.
3
P value based on test for linear trend using Satterthwaite adjusted F test
4
P value based on Satterthwaite adjusted F test
5
BMI categories (kg/m2): normal (18.5–<25), overweight (25–<30), obese (≥30)
6
Blood pressure categories (mm Hg): normal (SBP <120, DBP <80), prehypertension (SBP 120–139 or DBP 80–89), hypertension (SBP ≥140 or 
DBP ≥90)
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Table 3
Dietary sodium intake in US adults aged 20–59 y by demographic and health characteristics, NHANES 1988–
20101,2
1988–1994 2003–2006 2010 Ptrend value3
mg/d mg/d mg/d
All groups 3280 ± 83.3 3270 ± 68.2 3400 ± 87.6 0.34
Age group
  20–39 y 3340 ± 117 3390 ± 101 3490 ± 124 0.39
  40–59 y 3190 ± 114 3140 ± 92.3 3300 ± 125 0.51
  P value4 0.37 0.07 0.30
Sex
  Men 3950 ± 121 4030 ± 90.2 3940 ± 153 0.98
  Women 2670 ± 99 2580 ± 79.1 2970 ± 92.4 0.037
  P value4 <0.001 <0.001 <0.001
Race-ethnicity
  Mexican American 3000 ± 118 3130 ± 127 3060 ± 161 0.83
  Non-Hispanic black 3270 ± 114 2890 ± 133 3110 ± 179 0.33
  Non-Hispanic white 3320 ± 105 3370 ± 91.0 3470 ± 122 0.37
  P value4 0.44 0.039 0.054
BMI5
  Normal weight 3330 ± 120 3150 ± 117 3140 ± 136 0.27
  Overweight 3380 ± 171 3430 ± 107 3490 ± 145 0.64
  Obese 3060 ± 165 3370 ± 128 3640 ± 184 0.018
  P value4 0.54 0.10 0.06
Blood pressure6
  Normal 3200 ± 122 3220 ± 103 3120 ± 94.7 0.63
  Prehypertension 3360 ± 128 3350 ± 110 3930 ± 180 0.011
  Hypertension 3530 ± 194 3270 ± 110 3320 ± 399 0.49
  P value4 0.33 0.57 0.001
1
Values are crude geometric mean estimates ± SEMs [n are the same as in table 1 for 1988–1994 and 2003–2006; slightly lower n for 2010: 607 
(all groups), 298 (20–39 y), 309 (40–59 y), 293 (males), 314 (females), 103 (Mexican Americans), 114 (non-Hispanic blacks), 276 (non-Hispanic 
whites), 170 (normal weight), 197 (overweight), and 233 (obese)]. DBP, diastolic blood pressure; SBP, systolic blood pressure.
2
To optimize resources, we randomly sampled NHANES participants 20–59 y of age for urine sodium analysis based on blood pressure and 
sodium intake. The 1988–1994 urine samples were a convenience sample of 2550 NHANES examinees of which we selected 1249; for NHANES 
2003–2006, we selected 1241 participants from a 1/3 urine random subsample (1 excluded due to extreme BMI, 5 excluded due to missing BMI); 
for NHANES 2010, we included data from 525 persons from a 1/3 urine random subsample.
3
P value based on test for linear trend using Satterthwaite adjusted F test
4
P value based on Satterthwaite adjusted F test
5
BMI categories (kg/m2): normal (18.5–<25), overweight (25–<30), obese (≥30)
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6
Blood pressure categories (mm Hg): normal (SBP <120, DBP <80), prehypertension (SBP 120–139 or DBP 80–89), hypertension (SBP ≥140 or 
DBP ≥90)
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Table 4
Model adjusted means for estimated 24-h urine sodium excretion and dietary sodium intake in U.S. adults 20–
59 y of age by demographic and health characteristics, NHANES 1988–20101,2
Estimated 24hUNa excretion Dietary sodium intake
Model 1 Model 2 Model 1 Model 2
mg/d mg/d mg/d mg/d
Survey period
  1988–1994 3190 (3130–3240) 3230 (3180–3280) 3200 (3070–3340) 3210 (3080–3350)
  2003–2006 3260 (3230–3290) 3260 (3230–3280) 3300 (3220–3390) 3300 (3220–3390)
  2010 3330 (3270–3390) 3280 (3230–3330) 3410 (3260–3560) 3400 (3260–3550)
  Ptrend value3 0.004 0.22 0.07 0.10
Age group
  20–39 y 3210 (3170–3260) 3250 (3210–3290) 3400 (3280–3520) 3400 (3280–3530)
  40–59 y 3310 (3260–3360) 3270 (3230–3310) 3190 (3070–3300) 3180 (3070–3300)
  P value4 0.004 0.52 0.013 0.009
Sex
  Men 3670 (3640–3740) 3670 (3630–3720) 3990 (3870–4120) 4000 (3860–4120)
  Women 2790 (2750–2830) 2810 (2770–2840) 2680 (2580–2790) 2690 (2590–2800)
  P value4 <0.001 <0.001 <0.001 <0.001
Race-ethnicity
  Mexican American 3460 (3390–3530) 3360 (3300–3420) 3010 (2850–3170) 2990 (2830–3160)
  Non-Hispanic black 3390 (3320–3460) 3300 (3240–3360) 3030 (2860–3200) 3010 (2850–3180)
  Non-Hispanic white 3200 (3160–3240) 3230 (3190–3260) 3390 (3280–3500) 3390 (3280–3500)
  P value4 <0.001 0.001 0.001 0.001
BMI5
  Normal weight n/a 2910 (2860–2950) n/a 3240 (3110–3380)
  Overweight n/a 3220 (3170–3270) n/a 3290 (3160–3430)
  Obese n/a 3830 (3770–3880) n/a 3410 (3240–3580)
  P value4 <0.001 0.44
1
Values are model-adjusted means for estimated 24hUNa excretion (95% CI) and geometric means for dietary sodium intake (95% CI); the model-
adjusted least square mean or geometric mean has been derived from a multiple linear regression model containing age, sex, race-ethnicity, and 
survey period (model 1) or age, sex, race-ethnicity, BMI, and survey period (model 2)
2
To optimize resources, we randomly sampled NHANES participants 20–59 y of age for urine sodium analysis based on blood pressure and 
sodium intake. The 1988–1994 urine samples were a convenience sample of 2550 NHANES examinees of which we selected 1249; for NHANES 
2003–2006, we selected 1241 participants from a 1/3 urine random subsample (1 excluded due to extreme BMI, 5 excluded due to missing BMI); 
for NHANES 2010, we included data from 525 persons from a 1/3 urine random subsample.
3
P value based on test for linear trend using Satterthwaite adjusted F test
4
P value based on Satterthwaite adjusted F test
5
BMI categories (kg/m2): normal (18.5–<25), overweight (25–<30), obese (≥30)
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